Commitments	12 Months Ended
Dec. 31, 2019
Notes to Financial Statements
Note 7. Commitments	Note 7. Commitments Effective March 1, 2015, the Company entered into a lease agreement (the “Lease”) in the Pittsburgh Life Sciences Greenhouse at a monthly rate of $750. The Lease was renewed effective March 1, 2016 at a monthly rate of $800 through August 30, 2018. The lease was terminated in 2019. Rent expense for the years ended December 31, 2019 and 2018 was $0 and $6,400, respectively. The Company has subsequently entered into a lease for premises located at 4 Becker Farm Road, Suite 105, Roseland, New Jersey. See “Note 10. Subsequent Events” for further discussion. In connection with the Company’s anticipated regulatory filings, the Company has engaged StemCell Systems GmbH (“StemCell Systems”) to provide it with prototypes and related documents under various agreements. Pursuant to these engagements the Company incurred expenses of $314,189 and $80,229 during the years ended December 31, 2019 and 2018, respectively. Dr. Gerlach, from whom the Company purchased the “SkinGun^TM and the technology on which the CellMist^TM System technology is based, is a principal of StemCell Systems. On June 3, 2019, the Company entered into a Charitable Gift Agreement with the University of Pittsburgh (“University”), pursuant to which the Company committed to provide a charitable donation to the University in the agreement amount of $250,000 (the “Grant”). The Company will pay the Grant in four quarterly installments with the first payment made on or before July 1, 2019. During the years ended December 31, 2019 and 2018, the Company made payments totaling $125,000 and $0, respectively. At December 31, 2019, the balance remaining under this gift was $187,500 of which $62,500 was paid subsequent to December 31, 2019. Due to the terms of the Grant, the Company will recognize the related expense upon payment. Dr. Gerlach, from whom the Company purchased the SkinGun^TM technology, is a professor at the University. See also “Note 8. Related Party Transactions.”

Commitments

12 Months Ended

Dec. 31, 2019

Note 7. Commitments

Effective March 1, 2015, the Company entered into a lease agreement (the “Lease”) in the Pittsburgh Life Sciences Greenhouse at a monthly rate of $750. The Lease was renewed effective March 1, 2016 at a monthly rate of $800 through August 30, 2018. The lease was terminated in 2019. Rent expense for the years ended December 31, 2019 and 2018 was $0 and $6,400, respectively. The Company has subsequently entered into a lease for premises located at 4 Becker Farm Road, Suite 105, Roseland, New Jersey. See “Note 10. Subsequent Events” for further discussion.

In connection with the Company’s anticipated regulatory filings, the Company has engaged StemCell Systems GmbH (“StemCell Systems”) to provide it with prototypes and related documents under various agreements. Pursuant to these engagements the Company incurred expenses of $314,189 and $80,229 during the years ended December 31, 2019 and 2018, respectively. Dr. Gerlach, from whom the Company purchased the “SkinGun^TM and the technology on which the CellMist^TM System technology is based, is a principal of StemCell Systems.

On June 3, 2019, the Company entered into a Charitable Gift Agreement with the University of Pittsburgh (“University”), pursuant to which the Company committed to provide a charitable donation to the University in the agreement amount of $250,000 (the “Grant”). The Company will pay the Grant in four quarterly installments with the first payment made on or before July 1, 2019. During the years ended December 31, 2019 and 2018, the Company made payments totaling $125,000 and $0, respectively. At December 31, 2019, the balance remaining under this gift was $187,500 of which $62,500 was paid subsequent to December 31, 2019. Due to the terms of the Grant, the Company will recognize the related expense upon payment. Dr. Gerlach, from whom the Company purchased the SkinGun^TM technology, is a professor at the University.

See also “Note 8. Related Party Transactions.”